TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,045,000 | +241.5% | 13,887 | +21.7% | 0.06% | +243.8% |
| Q1 2022 | $306,000 | -32.9% | 11,410 | +19.3% | 0.02% | -42.9% |
| Q4 2021 | $456,000 | -34.6% | 9,561 | -8.9% | 0.03% | -28.2% |
| Q3 2021 | $697,000 | +2.0% | 10,494 | +19.8% | 0.04% | +5.4% |
| Q2 2021 | $683,000 | -23.4% | 8,757 | -7.2% | 0.04% | -27.5% |
| Q1 2021 | $892,000 | -32.0% | 9,434 | -12.4% | 0.05% | -46.3% |
| Q4 2020 | $1,312,000 | -60.8% | 10,768 | -71.9% | 0.10% | -12.8% |
| Q3 2020 | $3,351,000 | – | 38,354 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |